First published online November 2, 2007
Journal of Experimental Biology 210, 3979-3989 (2007)
Published by The Company of Biologists 2007
doi: 10.1242/jeb.006056
An antidiuretic peptide (Tenmo-ADFb) with kinin-like diuretic activity on Malpighian tubules of the house cricket, Acheta domesticus (L.)
Geoffrey M. Coast1,*,
Ronald J. Nachman2 and
David A. Schooley3
1 School of Biological and Chemical Sciences, Birkbeck, University of
London, Malet Street, London WC1E 7HX, UK
2 US Department of Agriculture, APMRU/SPARC, College Station, TX 77845,
USA
3 Biochemistry, University of Nevada, Reno, NV 89557, USA

View larger version (5K):
[in this window]
[in a new window]
|
Fig. 1. Peptides known to reduce primary urine production [Tenmo-ADFa (ADFa),
Tenmo-ADFb (ADFb) and Manse-CAP2b (CAP2b)] were tested
at 1 µmol l–1 for an effect on cricket tubules, along with
their second messenger cyclic GMP [1 mmol l–1 8-bromo cyclic
GMP (cGMP)]. The cricket kinin Achdo-KII (1 nmol l–1; AKII)
was included in the assay as a positive control. Bars represent mean values
for the change in rate of secretion ( pl mm–1
min–1) following addition of test compounds, and vertical
lines represent + 1 s.e.m. for the number of replicates indicated in
parentheses. Tenmo-ADFb and 8-bromo cyclic GMP significantly increased
(***P<0.001) fluid secretion, and the response to the
former was comparable to that of Achdo-KII.
|
|

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 2. Dose–response curves for the diuretic activity of (A) Tenmo-ADFb and
(B) Achdo-KII. Results are expressed as a percentage of the response to a
supramaximal concentration (1 nmol l–1) of Achdo-KII. Data
points are the means ± 1 s.e.m. of 7–10 replicates. Note the vast
difference in potency between Tenmo-ADFb (EC50 1.5 µmol
l–1) and Achdo-KII (EC50 10.2 pmol
l–1).
|
|

View larger version (5K):
[in this window]
[in a new window]
|
Fig. 3. Time course for the stimulation of fluid secretion by supramaximal
concentrations of Tenmo-ADFb (10 µmol l–1; solid symbols
and line) and Achdo-KII (1 nmol l–1; open symbols and dotted
line). Results are normalised by being expressed as a percentage of the
unstimulated rate of secretion at 45 min. Data points are the means ± 1
s.e.m. of 11–12 replicates. Fluid secretion increases rapidly following
addition of the individual peptides (downward arrow) and is not further
elevated when they are applied together (upward arrow).
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4. Secreted fluid pH and concentrations of K+, Na+ and
Cl– before (open bars) and after (solid bars) the addition of
10 µmol l–1 Tenmo-ADFb (ADFb), 1 nmol l–1
Achdo-KII (AKII) and 1 mmol l–1 8-bromo cyclic GMP (cGMP).
Bars represent the means + 1 s.e.m. for the number of replicates shown in
parentheses. Asterisks indicate where the change in composition following
addition of the secretagogue is significant in a paired t-test;
*P<0.05; **P<0.01;
***P<0.001.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5. Tenmo-ADFb (1 µmol l–1; ADFb) and Achdo-KII (1 nmol
l–1; AKII) have no effect on fluid secretion by tubules
incubated in low Cl– saline (one-tenth normal
[Cl–]). Bars represent the means + 1 s.e.m. of fluid
secretion by tubules in normal (open bars) and in low Cl–
(solid bars) saline. The number of replicates is shown in parentheses. In the
final experimental period, all tubules were moved to normal saline (+
chloride). Note that identical letters indicate mean values that do not differ
significantly i.e. P<0.05.
|
|

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 6. The chloride channel blocker DPC depresses basal secretion and reduces the
effect of (A) 10 µmol l–1 Tenmo-ADFb (+ADFb) and (B) 1
nmol l–1 Achdo-KII (+AKII). Bars represent the means + 1
s.e.m. for the number of replicates shown in parentheses. Tubules were held in
control saline (open bars) or moved to a saline containing 0.2 mmol
l–1 DPC in the first experimental period (+DPC; solid bars).
Identical letters indicate significant differences between mean rates of
secretion (P<0.01).
|
|

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 8. Representative recordings showing the change in transepithelial voltage
(Vt) following the addition of (A) 10 µmol
l–1 Tenmo-ADFb, (B) 1 nmol l–1 Achdo-KII and
(C) 1 mmol l–1 8-bromo cyclic GMP. Thick arrows show the time
of insertion (downward) and withdrawal (upward) of the microelectrode, and
thin arrows show when peptides were added. The horizontal bar in C shows when
8-bromo cyclic GMP was present in the perfusate, and the thin arrow indicates
the time of addition of 10 µmol l–1 Tenmo-ADFb.
|
|

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 9. (A) Representative recording of the transepithelial voltage
(Vt) before and after the addition of 0.2 mmol
l–1 diphenylamine-2-carboxylate (DPC) to the bathing saline.
DPC briefly depolarises Vt but does not inhibit the
spontaneous voltage oscillations. Nor does it prevent the reduction of
Vt by 10 µmol l–1 Tenmo-ADFb (thin
arrow; ADFb). (B) A representative recording of the basal membrane voltage
(Vb) showing this is not affected by the addition of
either 10 µmol l–1 Tenmo-ADFb or 1 nmol
l–1 Achdo-KII (AKII). Thick arrows mark the point of
insertion (downward) and withdrawal (upward) of the microelectrode, and
horizontal bars show when peptides were present in the perfusate.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 10. A representative recording of spontaneous contractions by a cricket hindgut
preparation challenged with first 10 µmol l–1 Tenmo-ADFb
(A), then 2 nmol l–1 Achdo-KII (B) and finally with saline
alone (C). Bars show when test substances were present in the perfusate.
|
|
© The Company of Biologists Ltd 2007